These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8374293)

  • 1. [Prenatal diagnosis and prevention of hemolytic disease of newborn].
    Fischer K
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():64-9. PubMed ID: 8374293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New possibilities in diagnosis of hemolytic diseases in newborns].
    Fischer K; Poschmann A; Grundmann A; Asmussen S
    Infusionsther Transfusionsmed; 1992 Aug; 19(4):208-13. PubMed ID: 1422082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New possibilities in diagnosing hemolytic disease of newborn infants].
    Fischer K; Poschmann A; Grundmann A; Asmussen S
    Beitr Infusionsther; 1992; 30():431-5. PubMed ID: 1284753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD; Rossi KQ; Krugh D; O'Shaughnessy RW
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prenatal diagnosis and therapy of hemolytic disease of the newborn].
    Fischer K; Poschmann A; Hellwege HH; Kitschke HJ; Carstensen M; Sprotte C; Schreer I
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):167-70. PubMed ID: 4010672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rhesus-erythroblastosis. Diagnosis, therapy, prevention].
    Maas DH; Schneider J
    Fortschr Med; 1976 May; 94(13):735-40. PubMed ID: 821837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prenatal genotyping of the RhD locus by polymerase chain reaction in fetus at risk of hemolytic disease].
    Misković B; Stipoljev F; Hadzisejdić I; Grahovac B
    Lijec Vjesn; 2008; 130(1-2):4-6. PubMed ID: 18589635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prediction of the severity of fetal erythroblastosis using the erythrocyte phagocytosis test and evaluating anti-Rh antibody titers and their levels by autoanalysis].
    Brojer E; Zupańska B; Lenkiewicz B; Góralski S; Lozińska D; Przybyszewska G; Seyfried H
    Pol Tyg Lek; 1990 Mar 10-26; 45(12-13):249-52. PubMed ID: 2122424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal typing of fetal DNA in cases of potential alloimmune haemolytic disease of the newborn: clinical benefit outweighs disadvantage.
    Shields JA
    Br J Biomed Sci; 1999; 56(1):49-55. PubMed ID: 10492915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a PCR-based assay for fetal Cw antigen genotyping in a patient with a history of moderately severe hemolytic disease of the newborn due to anti-Cw.
    Reiner AP; Teramura G; Aramaki KM
    Am J Perinatol; 1999; 16(6):277-81. PubMed ID: 10586980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perinatal hemolytic disease. Part 2: Prevention and management].
    Hohlfeld P; Wirthner D; Tissot JD
    J Gynecol Obstet Biol Reprod (Paris); 1998 Apr; 27(3):265-76. PubMed ID: 9648004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory identification of erythroblastosis fetalis.
    Kurtz EM; Pappas AA; Cannon A
    Ann Clin Lab Sci; 1982; 12(5):388-97. PubMed ID: 6814344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibody induction after intrauterine interventions].
    Hoch J; Giers G; Bald R; Hansmann M; Hanfland P
    Infusionsther Transfusionsmed; 1993 Jun; 20 Suppl 2():70-3. PubMed ID: 8374294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemolytic disease of the fetus: a plea for restraint.
    Spinnato JA
    Obstet Gynecol; 1992 Nov; 80(5):873-7. PubMed ID: 1407932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intrauterine rhesus diagnosis].
    Herrmann U
    Beitr Infusionsther; 1989; 24():214-20. PubMed ID: 2481541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte monolayer assay (MMA)--an efficient method for predicting the clinical significance of alloantibodies and the severity of hemolytic disease of the newborn.
    Garratty G
    Beitr Infusionsther; 1988; 21():236-9. PubMed ID: 2462981
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythroblastosis fetalis: identification, management, and prevention.
    Frigoletto FD; Umansky I
    Clin Perinatol; 1979 Sep; 6(2):321-30. PubMed ID: 117965
    [No Abstract]   [Full Text] [Related]  

  • 19. Monocyte monolayer assay as a predictor of severity of hemolytic disease of the fetus and newborn.
    Sacks DA; Nance SJ; Garratty G; Petrucha RA; Horenstein J; Fotheringham N
    Am J Perinatol; 1993 Nov; 10(6):428-31. PubMed ID: 8267805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preventive care and prenatal therapy of hemolytic disease of newborn].
    Stamm H
    Ther Ggw; 1971 Nov; 110(11):1657-8 passim. PubMed ID: 5003495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.